MDT vs. ABT, ISRG, BSX, SYK, BDX, EW, IDXX, DXCM, RMD, and STE
Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Medtronic vs.
Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.
Medtronic received 645 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 75.48% of users gave Medtronic an outperform vote while only 69.90% of users gave Abbott Laboratories an outperform vote.
Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 1.7%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.1%. Abbott Laboratories pays out 30.8% of its earnings in the form of a dividend. Medtronic pays out 85.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has raised its dividend for 53 consecutive years and Medtronic has raised its dividend for 48 consecutive years.
Abbott Laboratories currently has a consensus target price of $133.06, indicating a potential downside of 1.46%. Medtronic has a consensus target price of $95.00, indicating a potential upside of 5.62%. Given Medtronic's higher possible upside, analysts plainly believe Medtronic is more favorable than Abbott Laboratories.
Abbott Laboratories has higher revenue and earnings than Medtronic. Abbott Laboratories is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.
Abbott Laboratories has a net margin of 31.95% compared to Medtronic's net margin of 12.83%. Abbott Laboratories' return on equity of 20.74% beat Medtronic's return on equity.
Abbott Laboratories has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 1.1% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.2% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, Medtronic had 33 more articles in the media than Abbott Laboratories. MarketBeat recorded 105 mentions for Medtronic and 72 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.56 beat Medtronic's score of 0.96 indicating that Abbott Laboratories is being referred to more favorably in the media.
Summary
Abbott Laboratories beats Medtronic on 13 of the 21 factors compared between the two stocks.
Get Medtronic News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medtronic Competitors List
Related Companies and Tools
This page (NYSE:MDT) was last updated on 2/21/2025 by MarketBeat.com Staff
